Kala Bio (KALA) Research & Development (2016 - 2026)
Kala Bio (KALA) posted Research & Development of $59,000 for Q2 2026, down 99.1% from $6.23 million a year earlier and down 3.3% from the prior quarter.
Powered by 
Analysis
Kala Bio (KALA) Research & Development (2016 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Research & Development at Kala Bio was $6.61 million, down 70.9% year-over-year; for FY2025, it came in at $18.78 million, down 15.0% from FY2024.
- Annual Research & Development shows a five-year compound annual growth rate of 0.5% (FY2020 to FY2025).
- In prior years, Kala Bio's Research & Development was $22.09 million in FY2024 (+18.9%), $18.59 million in FY2023 (+5.3%), $17.65 million in FY2022 (+53.3%) and $11.52 million in FY2021 (-37.3%).
- The Q2 2026 figure stands as the lowest quarterly Research & Development in data going back to Q2 2016.
- On a year-over-year basis, Research & Development has declined in each of the last three quarters, with an average decline of 31.9% over the last eight quarters.
- The strongest year-over-year quarter for Research & Development in the past five years was Q3 2022, with growth of 87.1%; the weakest was Q2 2026, with a decline of 99.1%.
- According to Business Quant data, Research & Development for the three prior quarters was $61,000 (Q1 2026), $366,000 (Q4 2025) and $6.13 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 3.65 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 2.34 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 9.74 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | -2.85 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | -4.05 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 1.87 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 1.76 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 2.81 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 993.80 Mn |
| 10 | Kala Bio | 6.57 Mn | 6.57 Mn | - | 59,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 59,000.00 |
| Mar 31, 2026 | 61,000.00 |
| Dec 31, 2025 | 366,000.00 |
| Sep 30, 2025 | 6.13 Mn |
| Jun 30, 2025 | 6.23 Mn |
| Mar 31, 2025 | 6.06 Mn |
| Dec 31, 2024 | 5.26 Mn |
| Sep 30, 2024 | 5.17 Mn |
| Jun 30, 2024 | 5.32 Mn |
| Mar 31, 2024 | 6.35 Mn |
| Dec 31, 2023 | 4.72 Mn |
| Sep 30, 2023 | 5.55 Mn |
| Jun 30, 2023 | 4.28 Mn |
| Mar 31, 2023 | 4.04 Mn |
| Dec 31, 2022 | 3.32 Mn |
| Sep 30, 2022 | 5.39 Mn |
| Jun 30, 2022 | 4.47 Mn |
| Mar 31, 2022 | 4.47 Mn |
| Dec 31, 2021 | 2.41 Mn |
| Sep 30, 2021 | 2.88 Mn |
API Access
Kala Bio Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=KALA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "KALA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=KALA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();